Bridgeway Capital Management, LLC Mustang Bio, Inc. Transaction History

Bridgeway Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.32 - $0.52 $16,000 - $26,000	-50,000 Reduced 19.03%	212,800 $82,000
Q2 2022 Aug 15, 2022	SELL	$0.58 - $1.13 $28,999 - $56,499	-50,000 Reduced 15.98%	262,800 $154,000
Q4 2021 Feb 14, 2022	BUY	$1.66 - $2.64 $30,710 - $48,840	18,500 Added 6.29%	312,800 $519,000
Q3 2021 Nov 15, 2021	SELL	$2.58 - $3.36 $94,428 - $122,976	-36,600 Reduced 11.06%	294,300 $792,000
Q2 2021 Aug 16, 2021	BUY	$2.7 - $3.81 $60,750 - $85,725	22,500 Added 7.3%	330,900 $1.1 Million

Q1 2021 May 17, 2021	BUY	$3.02 - $5.16 $347,300 - $593,400	115,000 Added 59.46%	308,400 $1.02 Million
Q2 2020 Aug 14, 2020	BUY	$2.33 - $4.6 $46,600 - $92,000	20,000 Added 11.53%	193,400 $615,000
Q4 2019 Feb 14, 2020	BUY	$2.57 - $4.08 $182,213 - $289,272	70,900 Added 69.17%	173,400 $707,000
Q3 2019 Nov 14, 2019	BUY	$2.74 - $4.65 $246,600 - $418,500	90,000 Added 720.0%	102,500 $334,000
Q1 2019 May 15, 2019	SELL	$2.95 - $5.61 $147,500 - $280,500	-50,000 Reduced 80.0%	12,500 $43,000
Q4 2018 Feb 14, 2019	SELL	$2.3 - $5.78 $28,749 - $72,250	-12,500 Reduced 16.67%	62,500 $184,000
Q1 2018 May 15, 2018	BUY	$10.14 - $12.38 $760,500 - $928,500	75,000 New	75,000 $821,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $46.3M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.